Takeaways

#
  • Wald distinguished large-company leadership from a market in which too few stocks were participating.
  • He wanted small caps to establish a decisive higher high and saw regional-bank improvement as one possible contributor.
  • Technology offered both established leaders and software stocks reclaiming earlier breakout areas.
  • He preferred healthcare providers and services on relative strength; a biotechnology recovery depended more on broader participation.

Ari Wald did not need small stocks to outperform the largest technology companies. He did need them to participate. That distinction shaped his bullish market view on the November 30, 2023 Morning Show.

Speaking with JC Parets, Spencer Israel and Steve Strazza, Oppenheimer’s head of technical analysis separated narrow leadership from narrow participation. Large companies could lead while smaller ones still rose. He expected weaker areas to catch up, rather than the leaders falling back toward them.

Small caps still had something to prove

Wald thought the July-to-October correction had run its course. He pointed to the late-October breakdowns below 200-day moving averages that quickly reversed. Sellers had received bearish signals but failed to push prices lower, which he read as evidence of exhaustion.

He expected new market highs, while acknowledging that the broader advance remained incomplete. Small caps had yet to establish a decisive higher high, and he wanted a larger expansion in stocks reaching new highs. The quality of the next move would matter to his assessment of how long the cycle could continue.

Regional banks offered one possible source of improvement. Wald thought their weakness had obscured stronger groups within small caps and financials. He saw the banks forming a larger base after their earlier decline, with a recovery potentially helping the Russell index participate more fully.

Technology offered established leaders and emerging bases

Wald still favored technology. He saw room both for stocks that had already led and for smaller software companies recovering from long consolidations.

The discussion compared the capitalization-weighted technology fund XLK with the software and services fund XSW. Wald used the latter to show opportunities beyond the biggest names: stocks that had broken out in the second quarter, pulled back during the third-quarter correction and were reclaiming those breakout areas.

Their relative strength through the setback mattered to him. He was looking for improving price structures within a group he already considered attractive, rather than assuming every laggard would recover equally.

Healthcare required a view of its separate businesses

Wald resisted treating healthcare as a single trade. Medical devices, providers and services, large pharmaceutical companies and biotechnology were behaving differently. He preferred the relative strength in providers and services.

Biotechnology was a more conditional idea. XBI was near an area he associated with earlier turning points, but those recoveries had accompanied broader market rallies. For the fund to work, he thought participation needed to expand into weaker, lower-momentum stocks.

Questions and answers

#

Questions answered in the original 2023-11-30 episode.

What was the difference between narrow leadership and narrow participation?

Wald was comfortable with large companies outperforming as long as smaller stocks also participated in the advance. He wanted to see more evidence that the latter were joining the rally.

Link to this answer

Why did he focus on software beyond the largest technology stocks?

He saw software stocks reclaiming breakout levels after the third-quarter correction while retaining relative strength. XSW illustrated that potential for participation beyond the biggest names.

Link to this answer

What did his biotechnology view depend on?

He linked a possible XBI recovery to a broader rally that brought weaker, lower-momentum stocks into the advance. Providers and services were his preferred healthcare groups on relative strength.

Link to this answer

Adapted by Stock Market TV Editorial from the original video. Source date: . Article published: .